The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

I

Invivoscribe

Status

Not yet enrolling

Conditions

Hematologic Diseases

Study type

Observational

Funder types

Industry

Identifiers

NCT06222164
IVS-010-003

Details and patient eligibility

About

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Full description

Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
  2. Donor Age ≥ 18 years

Exclusion criteria

  1. Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
  2. The specimens/samples have previously been enrolled in a clinical study

Trial design

2,000 participants in 1 patient group

Residual Specimens
Description:
Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing.

Trial contacts and locations

1

Loading...

Central trial contact

Andrew Schut

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems